News for October 24th, 2007

Gadolinium MRI contrast agents linked to Nephrogenic Systemic Fibrosis

Gadolinium based MRI contrast agents and Nephrogenic Systemic Fibrosis/ Nephrogenic Fibrosing Dermopathy (/NFD) have been linked in yet another study. This time, researchers in Scotland have confirmed that based contrast agents used in MRI’s are strongly associated with the onset of this often fatal disorder in people suffering from pre-existing disease. Their findings only add to the growing body of evidence that shows a strong connection between /NFD and based contrast agents that are often used in MRIs.

Read the rest of this entry »